GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the inhibitor amprenavir (apv) in complex with a multi-drug resistant HIV-1 protease variant (L10I/G48V/I54V/V64I/V82A)REFER: flap+ in citation

Analyse Crystal structure of the inhibitor amprenavir (apv) in complex with a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3EKP
Type
protein
Length
396 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03369
Ligands
478, PO4
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DProtease (EC 3.4.23.16)protein996% helix, 55% strandP03369

Ligands and binding sites

  • 478 · {3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid tetrahydro-furan-3-yl ester · ligand · 2 copies · chains A, B, C, D
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B
  • ACT · Acetate ion · additive · 12 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13820.720.8339478
23950.710.8335478

Interfaces

2 interfaces between chains.

  • C–D · 1914 Ų buried · 36 hydrogen bonds · protein-protein
  • A–B · 1805 Ų buried · 38 hydrogen bonds · protein-protein

Compared structures

  • 3EKP · Crystal Structure of the inhibitor Amprenavir (APV) in complex with a multi-drug… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.